newsfilter
← Latest News
Business Wire·

Alpine Immune Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced that Mitchell Gold, M.D.,